7,500,000 SHARES OF COMMON STOCK OF SEELOS THERAPEUTICS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • March 12th, 2020 • Seelos Therapeutics, Inc. • Pharmaceutical preparations • New York
The Benchmark Company, LLC As the Representative of the Several underwriters, if any, named in Schedule I hereto c/o The Benchmark Company, LLC 150 East 58th Street, 17th Floor New York, New York 10155
